02 Build Your Personalized Plan Well determine whether GLP-1, tirzepatide, or non-GLP options are the best fit for you
Personalized Dosing Strategies in Practice Microdosing strategies have become a pivotal aspect of personalized medicine, especially with the use of click-counting methods in multi-dose pens, which offer a level of flexibility that is crucial for tailoring GLP-1 dosing to individual patient needs
Bertelli A, Cerrati A, Giovannini L, Mian M, Spaggiari P, Bertelli AA
Semaglutide and bupropion aid in weight loss by reducing appetite, regulating metabolism, and influencing the brains reward and energy systems

Food and Drug Administration (2023) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial, JAMA (2022) Liraglutide versus semaglutide for weight reduction-A cost needed to treat analysis, Obesity (2023) Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight/obesity and normoglycemia, prediabetes, or Type 2 diabetes: secondary analyses of pooled data from the SCALE clinical development program, Diabetes Care (2017) Hypoglycemia, Endocrine Society (2022) Wegovy drug label information, DailyMed (2023) Saxenda drug label information, DailyMed (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) What to know about popular weight loss meds, Texas Health (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice